Self-limited epilepsy with autonomic seizures: A case report
An 8-year-old male patient with no significant pathological history was admitted with complaints of generalized abdominal pain
Brivaracetam FDA-Approved for Pediatric Seizures
Brivaracetam, available in the form of tablets, oral solution and intravenous fluid (IV) is now FDA-approved for the treatment of partial-onset seizures in children as young as one month. Brivaracetam IV formulation is the only IV formulation approved in last 7 years to treat partial-onset seizures in children one month of age and older. As […]
Cannabidiol Gel for Children with Encephalopathies
In children with developmental and epileptic encephalopathies, use of topical cannabidiol gel along with antiseizure therapy can improve quality of life. The safety and tolerability of cannabidiol gel was studied on 48 children, aged 3 to 13 years, in an open-label, non-randomized controlled trial. After the initial month of baseline and titration period, patients were […]
Seizures as Primary Manifestation of Pediatric COVID-19
A systematic retrospective study established that seizures occur early and could be the primary manifestation of acute COVID-19 in children. The study included 175 children aged 6 months to 17 years, infected with COVID-19 out of which 11 had presented with seizures. It was found that these children may lack fever or other typical symptoms […]